- Syrian army and Iranian-backed militias push towards Idlib province
- Britain's May hails new optimism in Brexit talks after deal
- In The Last Of Us 2 "No One Is Safe," Director Says
- Street Fighter 30th Anniversary Collection Brings 12 Classic Titles To PS4, Xbox One, Switch
- Super Mario Run Dominates 2017 iOS Charts
- Netflix's Witcher Show Brings On Marvel Writer
- Uncharted Sales Reach Incredible New Heights
- Berlin police say bags of bullets found near Christmas market not link
- First Trailer For New Walking Dead Game Looks Pretty Great
- Interior secretary pushing controversial road project
- UN chief: 'America first' is 'detrimental to American interests'
- Hospital operators in merger talks to form U.S. industry leader: WSJ
- Mexican opposition leader Anaya to seek presidency in coalition
- Turkey's Erdogan calls Israel a 'child-murderer' state
- PS4 Pro and PSVR Holiday Price Cuts Available Now
- Grounded ferry in Calais refloated, passengers disembarked
- Nuclear destruction 'one impulsive tantrum away,' Nobel winners warn
- 'King of Spin' Max Clifford dies
- Roy Moore says he has never molested anyone
- How much is the GOP willing to sacrifice for a Senate seat?
UnitedHealth to buy DaVita primary care unit for $4.9 billion
(Reuters) - U.S. health insurer UnitedHealth Group Inc on Wednesday announced a $4.9 billion deal to buy a unit of DaVita Inc, looking to bolster its primary and urgent care services.
The all-cash deal is UnitedHealth’s second major acquisition in 2017 that aims to broaden its reach beyond insurance and boost its outpatient care services through a large network of clinics.
UnitedHealth bought Surgical Care Affiliates for about $2.3 billion in March.
The deal with Denver-based DaVita, which mainly provides dialysis services, will combine UnitedHealth’s Optum unit with DaVita’s physician network business that serves about 1.7 million patients each year through nearly 300 clinics.
Besides running urgent care clinics, Optum manages drug benefits and offers data analytics services to industry clients.
DaVita’s physician network unit recorded sales of $4.11 billion last year but had become a major drag on the company’s financial performance in recent quarters despite contributing 30 percent to total revenue.
News of the deal sent DaVita shares up 9.3 percent to $66.61 in premarket trading on Wednesday.
DaVita plans to use the proceeds of the sale for stock buybacks and to repay debt.
Reuters reported last month that DaVita was exploring a sale of its medical unit.
Reporting by Divya Grover in Bengaluru; Editing by Arun Koyyur and Sai Sachin Ravikumar
Our Standards:The Thomson Reuters Trust Principles.